Quick Takeaways
- Jack E. Stover has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $73,806.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Jack E. Stover
- Location
- Irvine, CA
- Summary
- The estimated net worth of Jack E. Stover is at least $73,806 dollars as of 10 Mar 2026. Jack E. Stover is the Director of Profusa, Inc. and owns shares of Profusa, Inc. (PFSA) stock worth about $58K. Jack E. Stover is the Director of Traws Pharma, Inc. and owns shares of Traws Pharma, Inc. (TRAW) stock worth about $15.8K.
- Signature
- /s/ Jack E. Stover
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Jack E. Stover and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Profusa, Inc. ($58,024).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Jack E. Stover
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| PFSA, NVACW | Profusa, Inc. | Director | $58,024 | 26 Jan 2026 | ||
| TRAW | Traws Pharma, Inc. | Director | $15,782 | 08 Mar 2026 | ||
| PMCB | PharmaCyte Biotech, Inc. | Director | 15 Aug 2022 | |||
| RNAZ | Transcode Therapeutics, Inc. | Director | 19 Dec 2025 |
Insider Transactions Reported by Jack E. Stover:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.